Skip to main content
Log in

Direkte Kosten für die Behandlung des Typ-2-Diabetes in Deutschland

Direct costs for the treatment of type 2 diabetes in Germany

  • Journal Club
  • Published:
Der Diabetologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Ng CS, Lee JY, Toh MP, Ko Y (2014) Cost-of-illness studies of diabetes mellitus: a systematic review. Diabetes Res Clin Pract 105:151–163

    Article  PubMed  Google Scholar 

  2. Kanavos P, Aardweg S, van den Schurer W (2012) Diabetes expenditure, burden of disease and management in 5 EU countries. http://www.lse.ac.uk/LSEHealthAndSocialCare/reseach/LSEHealth/MTRG/LSEDiabetesReport26Jan2012.pdf. Zugegriffen: 19. Okt. 2016

    Google Scholar 

  3. Rosella LC, Lebenbaum M, Fitzpatrick T, O’Reilly D, Wang J, Booth GL et al (2016) Impact of diabetes on healthcare costs in a population-based cohort: a cost analysis. Diabet Med 33:395–403

    Article  CAS  PubMed  Google Scholar 

  4. Müller N, Heller T, Freitag MH, Gerste B, Haupt CM, Wolf G et al (2015) Healthcare utilization of people with type 2 diabetes in Germany: an analysis based on health insurance data. Diabet Med 32:951–957

    Article  PubMed  Google Scholar 

  5. German Institute of Medical Documentation and Information (DIMDI) (2014) Information system for health care data (data transparency): data record description. http://www.dimdi.de/static/en/versorgungsdaten/index.htm. Zugegriffen: 18. Nov. 2016

    Google Scholar 

  6. Drösler S, Hasford J, Kurth B‑M, Schaefer M, Wasem J, Wille E (2011) Evaluationsbericht zum Jahresausgleich 2009 im Risikostrukturausgleich. https://www.bundesgesundheitsministerium.de/fileadmin/Dateien/Publikationen/Gesundheit/Forschungsberichte/Evaluationsbericht_zum_Jahresausgleich.pdf. Zugegriffen: 22. Febr. 2017

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. Jecht.

Ethics declarations

Interessenkonflikt

M. Jecht gibt an, dass kein Interessenkonflikt besteht.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jecht, M. Direkte Kosten für die Behandlung des Typ-2-Diabetes in Deutschland. Diabetologe 13, 358–359 (2017). https://doi.org/10.1007/s11428-017-0237-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11428-017-0237-3

Navigation